Nanjing Legend Biotech Co.

This is an early-stage study to test the safety and initial effects of an experimental treatment called LUCAR-G79. It is for adults with severe autoimmune diseases like lupus or scleroderma that have come back or not improved with standard treatments. The treatment involves colle…

This is a very early study to test the safety and initial effects of a new treatment called LUCAR-DKS1. It is for adults with severe autoimmune diseases like lupus or scleroderma that have come back or not improved with standard treatments. The treatment involves giving patients …

This is an early safety study to test a new type of treatment called LUCAR-G79D, a CAR-T cell therapy, in adults with severe lupus or inflammatory muscle disease that has not responded to other treatments. The main goal is to see if the treatment is safe, how the body handles it,…

This study is testing an experimental cell therapy called LCAR-F33S for people with multiple myeloma that has returned or stopped responding to standard treatments. Researchers will give the therapy to about 35 patients to check how safe it is and whether it can help control the …